Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations

Towards a cognitive neuroscience of self-awareness.

Neuroscience and biobehavioral reviews·2016

Effects of local anesthetics and calcium on the interaction of cholinergic ligands with the nicotinic receptor protein from Torpedo marmorata.

Molecular pharmacology·2015

Comparison of embryonic and adult torpedo acetylcholine receptor by sedimentation characteristics and antigenicity.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014

In vitro excitation of purified membrane fragments by cholinergic agonists : IV. Ultrastructure, at high resolution, of the AcChE-Rich and ATPase-rich microsacs.

The Journal of membrane biology·2013

In vitro excitation of purified membrane fragments by cholinergic agonists : III. Comparison of the dose-response curves to decamethonium with the corresponding binding curves of decamethonium to the cholinergic receptor.

The Journal of membrane biology·2013

In Vitro excitation of purified membrane fragments by cholinergic agonists : II. The permeability change caused by cholinergic agonists.

The Journal of membrane biology·2013

Mechanism of activity inversion for GluN2B-selective negative allosteric modulators.

Molecular pharmacology·2026

A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine.

Molecular pharmacology·2026

High potency μ-opioid receptor agonists engage sodium-bound receptor states.

Molecular pharmacology·2026

Regulation of transient receptor potential ankyrin-1 agonist-induced airway epithelial cell injury and repair by protein kinase C and p38 mitogen-activated kinase.

Molecular pharmacology·2026

The molecular geography of cell signaling diseases.

Molecular pharmacology·2026

Promotion of tumor cell senescence by the antibody-drug conjugate, sacituzumab govitecan.

Molecular pharmacology·2026

Exosomes From Toll-Like Receptor 4-Stimulated Lung Cancer Cells Modulate Macrophage Polarization.

Scandinavian journal of immunology·2026

Inhibition of CCN2/CTGF prevents heterotopic ossification in Fibrodysplasia Ossificans Progressiva.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

First-in-human phase Ia study of the covalent TEAD palmitoylation inhibitor BPI-460372 in patients with advanced solid tumors: pharmacokinetics, exposure-limited dosing, and early antitumor activity.

Biomarker research·2026

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities.

Biomarker research·2026

RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

Leukemia·2026

Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature.

European annals of otorhinolaryngology, head and neck diseases·2026

Related Experiment Videos

Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations

Related Concept Videos

Towards a cognitive neuroscience of self-awareness.

Effects of local anesthetics and calcium on the interaction of cholinergic ligands with the nicotinic receptor protein from Torpedo marmorata.

Comparison of embryonic and adult torpedo acetylcholine receptor by sedimentation characteristics and antigenicity.

In vitro excitation of purified membrane fragments by cholinergic agonists : IV. Ultrastructure, at high resolution, of the AcChE-Rich and ATPase-rich microsacs.

In vitro excitation of purified membrane fragments by cholinergic agonists : III. Comparison of the dose-response curves to decamethonium with the corresponding binding curves of decamethonium to the cholinergic receptor.

In Vitro excitation of purified membrane fragments by cholinergic agonists : II. The permeability change caused by cholinergic agonists.

Mechanism of activity inversion for GluN2B-selective negative allosteric modulators.

A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine.

High potency μ-opioid receptor agonists engage sodium-bound receptor states.

Regulation of transient receptor potential ankyrin-1 agonist-induced airway epithelial cell injury and repair by protein kinase C and p38 mitogen-activated kinase.

The molecular geography of cell signaling diseases.

Promotion of tumor cell senescence by the antibody-drug conjugate, sacituzumab govitecan.

Exosomes From Toll-Like Receptor 4-Stimulated Lung Cancer Cells Modulate Macrophage Polarization.

Inhibition of CCN2/CTGF prevents heterotopic ossification in Fibrodysplasia Ossificans Progressiva.

First-in-human phase Ia study of the covalent TEAD palmitoylation inhibitor BPI-460372 in patients with advanced solid tumors: pharmacokinetics, exposure-limited dosing, and early antitumor activity.

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities.

RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature.

Related Experiment Videos

Presence of alpha-cobratoxin and phospholipase A2 activity in thymopoietin preparations

Related Concept Videos

Related Articles